Roylance Rebecca, Droufakou Stavroula, Gorman Patricia, Gillett Cheryl, Hart Ian R, Hanby Andrew, Tomlinson Ian
Molecular and Population Genetics Laboratory, Cancer Research UK, 44 Lincoln's Inn Fields, London WC2A 3PX, UK.
J Pathol. 2003 May;200(1):53-8. doi: 10.1002/path.1326.
Grade I invasive ductal breast carcinomas have a specific pattern of genetic aberrations, namely gain of 1q and loss of 16q. This pattern is very similar to the changes seen in invasive lobular breast carcinomas (ILCs). The gene on 16q involved in ILC is known to be E-cadherin (CDH1). This study has investigated whether the same gene is responsible for grade I invasive ductal carcinoma (IDC), using allele imbalance analysis, mutation screening, and immunohistochemistry (IHC). The data suggest that despite the shared pattern of genetic aberrations seen in grade I IDC and ILC, CDH1 is not the target gene in low-grade ductal tumourigenesis.
I级浸润性导管癌具有特定的基因畸变模式,即1q获得和16q缺失。这种模式与浸润性小叶癌(ILC)中所见的变化非常相似。已知ILC中涉及的16q上的基因是E-钙粘蛋白(CDH1)。本研究使用等位基因不平衡分析、突变筛查和免疫组织化学(IHC),调查了同一基因是否与I级浸润性导管癌(IDC)有关。数据表明,尽管I级IDC和ILC中存在共同的基因畸变模式,但CDH1不是低级别导管肿瘤发生中的靶基因。